1.
Braz. j. infect. dis
;
16(6): 606-607, Nov.-Dec. 2012.
Article
in English
| LILACS
| ID: lil-658937
Subject(s)
Humans , Male , Middle Aged , Acetamides/adverse effects , Angioedema/chemically induced , Anti-Infective Agents/adverse effects , Oxazolidinones/adverse effects , Urticaria/chemically induced , Gram-Positive Bacterial Infections/drug therapy , Renal Insufficiency , Renal Insufficiency, Chronic/microbiology
2.
Indian Pediatr
;
2004 Nov; 41(11): 1129-32
Article
in English
| IMSEAR
| ID: sea-12921
ABSTRACT
Linezolid is an oxazolidinone antibacterial agent that acts by inhibiting the initiation of bacterial protein synthesis. Linezolid has a wide spectrum of activity against gram-positive organisms including methicillin resistant staphylococci, penicillin resistant pneumococci and vancomycin resistant enterococcus faecalis and E. faecium. Linezolid has a good bio-availability orally and could be switched from parenteral to oral therapy while treating serious infections. Linezolid is well tolerated in children.
Subject(s)
Acetamides/adverse effects , Adult , Anti-Bacterial Agents/adverse effects , Child , Gram-Positive Bacterial Infections/drug therapy , Humans , Oxazolidinones/adverse effects , Protein Biosynthesis/drug effects , Protein Synthesis Inhibitors/adverse effects
3.
Bol. inf. medicam. (Santiago de Chile)
;
19(1): 6-9, mar. 2002. ilus
Article
in Spanish
| LILACS
| ID: lil-392152